Overview

A Thorough Corrected QT Interval Trial

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the effects of K-877 on ECG parameters with a focus on cardiac repolarization compared with placebo in healthy adult subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Kowa Research Institute, Inc.

Treatments:

Moxifloxacin